This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Arrowhead Pharmaceuticals, Inc., Arrowhead Research Corporation, Novartis Ag. Active years: 2013-2019.
Company Filing History:
1 out of 102 
1 out of 18 
1 out of 3,973 
Years Active: 2013-2019
Title: Jason Borawski: Innovator in Viral Infection Treatment
Introduction
Jason Borawski is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for viral infections. With a total of 3 patents to his name, Borawski's work focuses on innovative approaches to combat diseases caused by positive stranded RNA viruses.
Latest Patents
One of Borawski's latest patents involves the use of double-stranded ribonucleic acids (dsRNAs) for treating viral infections. This invention targets the gene expression of phosphatidylinositol 4-kinase (PI4K), specifically the human phosphatidylinositol 4-kinase, catalytic, beta polypeptide (PIK4CB) and the alpha polypeptide (PIK4CA). The dsRNAs are designed to treat infections caused by positive stranded RNA viruses, such as the hepatitis C virus (HCV). Each dsRNA consists of an antisense strand with a nucleotide sequence of less than 30 nucleotides, typically ranging from 19 to 25 nucleotides, which is substantially complementary to parts of the target mRNA. The invention also includes a pharmaceutical composition that combines the dsRNA with a pharmaceutically acceptable carrier, utilizing delivery modalities like fully encapsulated liposomes or lipid complexes. Furthermore, it outlines methods for treating diseases caused by positive stranded RNA virus infections and inhibiting the propagation of these viruses in and between cells.
Career Highlights
Throughout his career, Jason Borawski has worked with prominent companies in the biotechnology sector. He has been associated with Arrowhead Research Corporation and Novartis AG, where he has contributed to various innovative projects. His expertise in the field has allowed him to develop groundbreaking solutions that address critical health challenges.
Collaborations
Some of Borawski's notable coworkers include Mark Aron Labow and Larry Alexander Gaither. Their collaborative efforts have further advanced the research and development of therapeutic strategies in the biotechnology industry.
Conclusion
Jason Borawski's innovative work in the field of viral infection treatment exemplifies the impact of biotechnology on public health. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.